Orchestra BioMed Holdings, Inc. (OBIO)

Orchestra BioMed Holdings Revenue

Orchestra BioMed Holdings had revenue of $110.00K in the quarter ending March 31, 2026, a decrease of -87.33%. This brings the company's revenue in the last twelve months to $32.72M, up 1,033.89% year-over-year. In the year 2025, Orchestra BioMed Holdings had annual revenue of $33.48M with 1,169.22% growth.

• Revenue (ttm): $32.72M
• Revenue Growth: +1,033.89%
• P/S Ratio: 7.15
• Revenue / Employee: $380,512
• Employees: 86
• Market Cap: 234.13M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	33.48M	30.84M	1,169.22%
Dec 31, 2024	2.64M	-122.00K	-4.42%
Dec 31, 2023	2.76M	-773.00K	-21.88%
Dec 31, 2022	3.53M	4.32M	-
Dec 31, 2021	-782.00K	-6.49M	-

Data Source: S&P Global Market Intelligence Last updated: Mar 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 28, 2026

Data Sources Report a data error